• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创伤性脑损伤后格拉斯哥预后量表的健康状态偏好权重:一项系统评价与图谱研究

Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.

作者信息

Ward Fuller Gordon, Hernandez Monica, Pallot David, Lecky Fiona, Stevenson Mathew, Gabbe Belinda

机构信息

Emergency Medicine Research in Sheffield, Health Services Research Section, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, South Yorkshire, UK.

School of Health and Related Research, University of Sheffield, Sheffield, South Yorkshire, UK.

出版信息

Value Health. 2017 Jan;20(1):141-151. doi: 10.1016/j.jval.2016.09.2398. Epub 2016 Dec 28.

DOI:10.1016/j.jval.2016.09.2398
PMID:28212955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5339086/
Abstract

BACKGROUND

Valid and relevant estimates of health state preference weights (HSPWs) for Glasgow Outcome Scale (GOS) categories are a key input of economic models evaluating treatments for traumatic brain injury (TBI).

OBJECTIVES

To characterize existing HSPW estimates, and model the EuroQol five-dimensional questionnaire (EQ-5D) from the GOS, to inform parameterization of future economic models.

METHODS

A systematic review of HSPWs for GOS categories following TBI was conducted using a highly sensitive search strategy implemented in an extensive range of information sources between 1975 and 2016. A cross-sectional mapping study of GOS health states onto the three-level EQ-5D UK tariff index values was also performed in patients with significant TBI (head region Abbreviated Injury Scale score ≥3) from the Victoria State Trauma Registry. A limited dependent variable mixture model was used to estimate the 12-month EQ-5D UK value set as a function of GOS category, age, and other explanatory variables.

RESULTS

Six unique HSPWs from five eligible studies were identified. All studies were at high risk of bias with limited applicability. The magnitude of HSPWs differed significantly between studies. Three class mixture models demonstrated excellent goodness of fit to the observed Victoria State Trauma Registry data. GOS category, age at injury, sex, comorbidity, and major extracranial injury all had significant independent effects on mean EQ-5D utility values.

CONCLUSIONS

The few available HSPWs for GOS categories are challenged by potential biases and restricted generalizability. Mixture models are presented to provide HSPWs for GOS categories consistent with the National Institute for Health and Care Excellence reference case.

摘要

背景

格拉斯哥预后量表(GOS)各分类的健康状态偏好权重(HSPW)的有效且相关的估计值,是评估创伤性脑损伤(TBI)治疗方法的经济模型的关键输入。

目的

描述现有的HSPW估计值,并根据GOS对欧洲五维健康量表(EQ-5D)进行建模,以为未来经济模型的参数化提供信息。

方法

采用高灵敏度搜索策略,对1975年至2016年间广泛信息来源中有关TBI后GOS各分类的HSPW进行系统评价。还对维多利亚州创伤登记处中严重TBI(头部区域简明损伤量表评分≥3)患者的GOS健康状态与三级EQ-5D英国关税指数值进行了横断面映射研究。使用有限因变量混合模型来估计作为GOS分类、年龄和其他解释变量函数的12个月EQ-5D英国值集。

结果

从五项符合条件的研究中确定了六个独特的HSPW。所有研究都存在高偏倚风险且适用性有限。不同研究之间HSPW的大小差异显著。三种类别混合模型对观察到的维多利亚州创伤登记处数据显示出极佳的拟合优度。GOS分类、受伤时年龄、性别、合并症和主要颅外损伤均对平均EQ-5D效用值有显著独立影响。

结论

GOS各分类现有的少数HSPW受到潜在偏倚和普遍适用性受限的挑战。提出了混合模型,以提供与英国国家卫生与临床优化研究所参考案例一致的GOS各分类的HSPW。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/bbd3f6940555/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/6f5a25f2851f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/a742ba159e38/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/2399bfab14fc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/bbd3f6940555/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/6f5a25f2851f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/a742ba159e38/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/2399bfab14fc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615e/5339086/bbd3f6940555/gr4.jpg

相似文献

1
Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.创伤性脑损伤后格拉斯哥预后量表的健康状态偏好权重:一项系统评价与图谱研究
Value Health. 2017 Jan;20(1):141-151. doi: 10.1016/j.jval.2016.09.2398. Epub 2016 Dec 28.
2
Evaluation of the ventricular assist device programme in the UK.英国心室辅助装置项目评估
Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Negative pressure wound therapy for open traumatic wounds.开放性创伤伤口的负压伤口治疗
Cochrane Database Syst Rev. 2018 Jul 3;7(7):CD012522. doi: 10.1002/14651858.CD012522.pub2.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
A Survey to Determine Health Utility States After a Traumatic Brain Injury (TBI): Influence of a History of TBI on Disability Perceptions.一项关于创伤性脑损伤(TBI)后健康效用状态的调查:TBI病史对残疾认知的影响。
Cureus. 2024 Oct 2;16(10):e70707. doi: 10.7759/cureus.70707. eCollection 2024 Oct.
2
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.系统评价研究中健康状态效用值研究的质量评价:概念性考虑。
Pharmacoeconomics. 2024 Jul;42(7):767-782. doi: 10.1007/s40273-024-01365-z. Epub 2024 Mar 29.
3
Effects of clinical nursing pathway on postoperative satisfaction and quality of life of patients with subarachnoid hemorrhage.

本文引用的文献

1
Modeling Health State Utility Values in Ankylosing Spondylitis: Comparisons of Direct and Indirect Methods.强直性脊柱炎健康状态效用值建模:直接法与间接法的比较
Value Health. 2015 Jun;18(4):425-31. doi: 10.1016/j.jval.2015.02.016. Epub 2015 May 16.
2
Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D.建立骨关节炎指数(WOMAC)与欧洲五维度健康量表(EQ-5D)之间的关系模型。
Health Qual Life Outcomes. 2014 Mar 12;12:37. doi: 10.1186/1477-7525-12-37.
3
A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes.
临床护理路径对蛛网膜下腔出血患者术后满意度及生活质量的影响
Pak J Med Sci. 2024 Mar-Apr;40(4):747-752. doi: 10.12669/pjms.40.4.7800.
4
Clinical effect of high-flow revascularization in microsurgery combined with endoscopic endonasal surgery for skull base tumors with intracranial and extracranial involvement.高流量血管重建显微手术联合鼻内镜下经鼻手术治疗累及颅内和颅外的颅底肿瘤的临床效果
Front Surg. 2023 Jan 6;9:1019400. doi: 10.3389/fsurg.2022.1019400. eCollection 2022.
5
Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis.健康状态效用值的系统文献综述质量评价:描述性分析。
BMC Med Res Methodol. 2022 Nov 25;22(1):303. doi: 10.1186/s12874-022-01784-6.
6
Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L.将患者报告结局测量信息系统(PROMIS-29)映射至 EQ-5D-5L。
Pharmacoeconomics. 2023 Feb;41(2):187-198. doi: 10.1007/s40273-022-01157-3. Epub 2022 Nov 7.
7
A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury.用于为经历轻度创伤性脑损伤的老年人提供氨甲环酸的未来研究提供信息的成本效益和价值分析。
Trials. 2022 May 3;23(1):370. doi: 10.1186/s13063-022-06244-6.
8
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.基于 BASDAI 和 BASFI 生成 EQ-5D-5L 健康效用评分:使用英国纵向登记数据的中轴型脊柱关节炎患者的映射研究。
Eur J Health Econ. 2022 Nov;23(8):1357-1369. doi: 10.1007/s10198-022-01429-x. Epub 2022 Feb 3.
9
Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer.将 EORTC QLQ-C30 量表映射到乳腺癌患者的 EQ-5D-3L 量表中。
BMC Cancer. 2021 Nov 18;21(1):1237. doi: 10.1186/s12885-021-08964-5.
10
Microsurgical clipping vs. arterial embolization in the treatment of ruptured anterior circulation aneurysms.显微外科夹闭术与动脉栓塞术治疗破裂性前循环动脉瘤的比较。
Am J Transl Res. 2021 Jul 15;13(7):8040-8048. eCollection 2021.
从临床结果估计健康效用的直接方法与间接方法的比较。
Med Decis Making. 2014 Oct;34(7):919-30. doi: 10.1177/0272989X13500720. Epub 2013 Sep 11.
4
Time trade-off: one methodology, different methods.时间权衡:一种方法,多种方法。
Eur J Health Econ. 2013 Jul;14 Suppl 1(Suppl 1):S53-64. doi: 10.1007/s10198-013-0508-x.
5
Longitudinal description of the glasgow outcome scale-extended for individuals in the traumatic brain injury model systems national database: a National Institute on Disability and Rehabilitation Research traumatic brain injury model systems study.创伤性脑损伤模型系统国家数据库中个体的格拉斯哥结局量表扩展的纵向描述:国家残疾研究所和康复研究创伤性脑损伤模型系统研究。
Arch Phys Med Rehabil. 2013 Dec;94(12):2486-2493. doi: 10.1016/j.apmr.2013.06.021. Epub 2013 Jul 6.
6
The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis.类风湿关节炎患者的 EQ-5D、HAQ 与疼痛之间的关系。
Rheumatology (Oxford). 2013 May;52(5):944-50. doi: 10.1093/rheumatology/kes400. Epub 2013 Jan 21.
7
Using health state utility values in models exploring the cost-effectiveness of health technologies.在探索卫生技术成本效益的模型中使用健康状态效用值。
Value Health. 2012 Sep-Oct;15(6):971-4. doi: 10.1016/j.jval.2012.05.003. Epub 2012 Jun 15.
8
Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.峰区之尾:调整后的 EQ-5D 问卷健康状态效用值有限依赖变量混合模型。
Value Health. 2012 May;15(3):550-61. doi: 10.1016/j.jval.2011.12.014. Epub 2012 Mar 23.
9
Relating quality of life to Glasgow outcome scale health states.将生活质量与格拉斯哥结局量表健康状况相联系。
J Neurotrauma. 2012 May 1;29(7):1322-7. doi: 10.1089/neu.2011.2222. Epub 2012 Apr 17.
10
Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis.比较用于资源配置的健康状态效用的直接和间接估计方法:综述与实证分析。
BMJ. 2009 Jul 22;339:b2688. doi: 10.1136/bmj.b2688.